Literature DB >> 2449833

The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury.

A S Shen1, C Haslett, D C Feldsien, P M Henson, R M Cherniack.   

Abstract

Interstitial lung disease is thought to result from progression of an initial lung injury and alveolitis into a chronic inflammatory process that produces fibrosis. However, the relationship between the severity of the initial phase of acute injury and alveolitis and the amount of subsequent chronic inflammation and fibrosis remains unclear. We induced a wide spectrum of acute lung injury in rabbits by using various amounts of intratracheal bleomycin (5 or 10 U/kg) with and without oxygen supplementation (100% O2 for 2 min). The arterial oxygen tension on Day 12 after the bleomycin correlated with the extent of acute lung injury, as well as with the amount of chronic inflammation and fibrosis present on Day 56, as determined by physiologic parameters (lung volume, DLCO/VA, and PO2), and morphometry (volume proportions abnormal parenchyma made up of intra-alveolar macrophages, intra-alveolar granulocytes, abnormal alveoli, abnormal airways, fibrosis, consolidation, and honeycombing). We conclude that in bleomycin-induced interstitial lung disease in the rabbit, there is a direct relationship between the severity of acute lung injury after intratracheal bleomycin and the amount of subsequent chronic inflammation and fibrosis. This suggests that the mechanisms regulating the development of fibrosis are directly influenced by the extent of initial injury.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449833     DOI: 10.1164/ajrccm/137.3.564

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.

Authors:  N Kaminski; J D Allard; J F Pittet; F Zuo; M J Griffiths; D Morris; X Huang; D Sheppard; R A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells.

Authors:  Sarah J Ohle; Asha Anandaiah; Attila J Fabian; Alan Fine; Darrell N Kotton
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-09       Impact factor: 6.914

3.  Beta-catenin in the fibroproliferative response to acute lung injury.

Authors:  Ivor S Douglas; Fernando Diaz del Valle; Robert A Winn; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-04       Impact factor: 6.914

4.  Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation.

Authors:  Ting Xie; Jiurong Liang; Rishu Guo; Ningshan Liu; Paul W Noble; Dianhua Jiang
Journal:  Physiol Genomics       Date:  2011-01-25       Impact factor: 3.107

5.  β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix.

Authors:  Alysia Kern Lovgren; Jeffrey J Kovacs; Ting Xie; Erin N Potts; Yuejuan Li; W Michael Foster; Jiurong Liang; Eric B Meltzer; Dianhua Jiang; Robert J Lefkowitz; Paul W Noble
Journal:  Sci Transl Med       Date:  2011-03-16       Impact factor: 17.956

6.  Prevention of bleomycin-induced fibrosing alveolitis with indomethacin: stereological studies on rat lungs.

Authors:  G Mall; P Zimmermann; I Siemens; A Burkhardt; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

Authors:  D T Eitzman; R D McCoy; X Zheng; W P Fay; T Shen; D Ginsburg; R H Simon
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 8.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

9.  Induced pluripotent stem cell-conditioned medium suppresses pulmonary fibroblast-to-myofibroblast differentiation via the inhibition of TGF-β1/Smad pathway.

Authors:  Yan Zhou; Qiang Zhang; Yuan Gao; Mingqi Tan; Rui Zheng; Li Zhao; Xiaoye Zhang
Journal:  Int J Mol Med       Date:  2017-10-19       Impact factor: 4.101

10.  FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts.

Authors:  Markaisa Black; David Milewski; Tien Le; Xiaomeng Ren; Yan Xu; Vladimir V Kalinichenko; Tanya V Kalin
Journal:  Cell Rep       Date:  2018-04-10       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.